Acquired by Mars in June 2023
HSKA - Heska Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Loveland,
United States
Type: Equity
HSKA price evolution
HSKA
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $125.21 | $156.62 | $161.07 | $171.93 |
| Short term investments | $10.48 | $7.43 | $6.9 | $6.67 |
| Net receivables | $26.05 | $38.73 | $26.41 | $27.89 |
| Inventory | $64.18 | $60.05 | $57.48 | $55.8 |
| Total current assets | $238.62 | $265.03 | $262.81 | $272.87 |
| Long term investments | $30.2 | $47.19 | $44.32 | $38.85 |
| Property, plant & equipment | $68.13 | $39.07 | $37.87 | $40.27 |
| Goodwill & intangible assets | $211.22 | $198.31 | $190.4 | $201.06 |
| Total noncurrent assets | $354.09 | $320.78 | $307.25 | $313.92 |
| Total investments | $40.68 | $54.63 | $51.22 | $45.51 |
| Total assets | $592.72 | $585.82 | $570.07 | $586.79 |
| Current liabilities | ||||
| Accounts payable | $12.25 | $16.4 | $14.75 | $12.05 |
| Deferred revenue | $10.56 | $9.18 | $8.47 | $9.32 |
| Short long term debt | $4.05 | $2.94 | $2.68 | $2.55 |
| Total current liabilities | $42.3 | $39.58 | $36.59 | $39.46 |
| Long term debt | $105.38 | $95.9 | $102.58 | $105.74 |
| Total noncurrent liabilities | $132.75 | $124.03 | $125.58 | $130.04 |
| Total debt | $109.43 | $103.07 | $105.27 | $108.29 |
| Total liabilities | $175.04 | $163.61 | $162.17 | $169.5 |
| Shareholders' equity | ||||
| Retained earnings | -$178.66 | -$168.53 | -$164.31 | -$163.88 |
| Other shareholder equity | -$3.91 | -$6.51 | -$21.04 | -$9.39 |
| Total shareholder equity | $417.67 | $422.21 | $407.9 | $417.29 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $156.62 | $223.57 | $86.33 | $89.03 |
| Short term investments | $7.43 | $6.17 | $4.79 | $3.86 |
| Net receivables | $38.73 | $28 | $31.08 | $15.16 |
| Inventory | $60.05 | $49.36 | $40.04 | $26.6 |
| Total current assets | $265.03 | $319.56 | $171.28 | $139.87 |
| Long term investments | $47.19 | $40.8 | $29.16 | $21.73 |
| Property, plant & equipment | $39.07 | $38.61 | $41 | $21.2 |
| Goodwill & intangible assets | $198.31 | $175.53 | $144.27 | $47.68 |
| Total noncurrent assets | $320.78 | $284.52 | $228.56 | $104.56 |
| Total investments | $54.63 | $46.98 | $33.96 | $25.59 |
| Total assets | $585.82 | $604.07 | $399.84 | $244.42 |
| Current liabilities | ||||
| Accounts payable | $16.4 | $15.37 | $15.12 | $6.6 |
| Deferred revenue | $9.18 | $10.76 | $11.52 | $8.9 |
| Short long term debt | $2.94 | $2.23 | $2.09 | $1.75 |
| Total current liabilities | $39.58 | $43.93 | $42.12 | $32.2 |
| Long term debt | $95.9 | $103.44 | $52.87 | $50.88 |
| Total noncurrent liabilities | $124.03 | $124.29 | $70.67 | $57.69 |
| Total debt | $103.07 | $105.67 | $54.96 | $52.63 |
| Total liabilities | $163.61 | $168.22 | $112.79 | $89.89 |
| Shareholders' equity | ||||
| Retained earnings | -$168.53 | -$148.64 | -$150.86 | -$136.44 |
| Other shareholder equity | -$6.51 | $5.04 | $14.17 | $0.51 |
| Total shareholder equity | $422.21 | $435.85 | $287.05 | $154.36 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $62.38 | $66.34 | $61.49 | $64.68 |
| Cost of revenue | $34.98 | $38.52 | $34.62 | $37.35 |
| Gross Profit | $27.4 | $27.82 | $26.88 | $27.33 |
| Operating activities | ||||
| Research & development | $3.09 | $2.59 | $2.38 | $2.33 |
| Selling, general & administrative | $34.73 | $27.86 | $25.16 | $30.55 |
| Total operating expenses | $37.82 | $30.45 | $27.55 | $32.87 |
| Operating income | -$10.42 | -$2.63 | -$0.67 | -$5.54 |
| Income from continuing operations | ||||
| EBIT | -$10.77 | -$3 | -$1.03 | -$5.9 |
| Income tax expense | -$0.38 | $0.77 | -$0.83 | -$1.13 |
| Interest expense | -$0.27 | $0.46 | $0.24 | $0.48 |
| Net income | ||||
| Net income | -$10.13 | -$4.22 | -$0.44 | -$5.25 |
| Income (for common shares) | -$10.13 | -$4.22 | -$0.44 | -$5.25 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $257.31 | $253.74 | $197.32 | $122.66 |
| Cost of revenue | $146.14 | $147.94 | $116.03 | $68.21 |
| Gross Profit | $111.17 | $105.79 | $81.29 | $54.45 |
| Operating activities | ||||
| Research & development | $19.75 | $6.98 | $8.77 | $8.24 |
| Selling, general & administrative | $111.71 | $99.81 | $80.71 | $45.88 |
| Total operating expenses | $131.47 | $106.79 | $89.48 | $54.12 |
| Operating income | -$20.3 | -$0.99 | -$8.19 | $0.33 |
| Income from continuing operations | ||||
| EBIT | -$21.76 | -$2.27 | -$8.56 | -$0 |
| Income tax expense | -$3.41 | -$3.57 | $0.24 | -$1.45 |
| Interest expense | $1.54 | $2.45 | $5.6 | $2.91 |
| Net income | ||||
| Net income | -$19.89 | -$1.15 | -$14.4 | -$1.47 |
| Income (for common shares) | -$19.89 | -$1.15 | -$14.4 | -$1.47 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$10.13 | -$4.22 | -$0.44 | -$5.25 |
| Operating activities | ||||
| Depreciation | $3.97 | $3.64 | $3.5 | $3.53 |
| Business acquisitions & disposals | -$20.67 | $0.55 | ||
| Stock-based compensation | $3.08 | $3.69 | $2.32 | $4.88 |
| Total cash flows from operations | -$9.16 | -$3.16 | -$2.04 | $1.05 |
| Investing activities | ||||
| Capital expenditures | -$1.89 | -$0.51 | -$0.51 | -$0.76 |
| Investments | -$4.7 | |||
| Total cash flows from investing | -$22.56 | -$0.51 | -$4.65 | -$0.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $0.35 | $0.59 | $0.48 |
| Net borrowings | -$0.04 | -$2.43 | -$2.43 | -$0.05 |
| Total cash flows from financing | -$0.13 | -$2.12 | -$2.06 | $0.39 |
| Effect of exchange rate | $0.44 | $1.34 | -$2.11 | -$1.5 |
| Change in cash and equivalents | -$31.41 | -$4.46 | -$10.85 | -$0.82 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$19.89 | -$1.15 | -$14.4 | -$1.47 |
| Operating activities | ||||
| Depreciation | $13.97 | $13.55 | $11.38 | $4.92 |
| Business acquisitions & disposals | -$28.96 | -$24.64 | -$119.27 | -$0.88 |
| Stock-based compensation | $16 | $18.26 | $9.49 | $4.97 |
| Total cash flows from operations | -$21.81 | $6.25 | -$0.66 | $3.3 |
| Investing activities | ||||
| Capital expenditures | -$2.11 | -$1.36 | -$0.68 | -$1.04 |
| Investments | -$4.7 | -$9 | -$6.65 | |
| Total cash flows from investing | -$35.77 | -$35 | -$126.6 | -$1.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.19 | $168.92 | $2.8 | -$1.62 |
| Net borrowings | -$4.97 | -$0.88 | -$0.82 | $75.88 |
| Total cash flows from financing | -$7.05 | $166.4 | $123.76 | $74.26 |
| Effect of exchange rate | -$2.32 | -$0.41 | $0.79 | $0 |
| Change in cash and equivalents | -$66.96 | $137.24 | -$2.7 | $75.64 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 10.92M |
| Revenue | $254.89M |
|---|---|
| EBITDA | -$6.06M |
| EBIT | -$20.70M |
| Net Income | -$20.03M |
| Revenue Q/Q | -3.73% |
| Revenue Y/Y | -1.22% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 38.62 |
| Cash/Share | 11.47 |
| EPS | -$1.83 |
|---|---|
| ROA | -3.43% |
| ROE | -4.81% |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | -8.22 |
| Current ratio | 5.64 |
| Quick ratio | 4.12 |